查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1422784

移植市場依產品（組織產品、免疫抑制藥物、保存液）、應用（器官移植、組織移植）、最終用戶（醫院、移植中心等）及地區2024-2032

Transplantation Market by Product (Tissue Products, Immunosuppressive Drugs, Preservation Solution), Application (Organ Transplantation, Tissue Transplantation), End User (Hospitals, Transplantation Centers, and Others), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

2023年全球移植市場規模達160億美元。展望未來， IMARC Group預計到2032年市場規模將達到336億美元，2024-2032年複合年成長率（CAGR）為8.39%。由於醫療技術的快速進步、慢性病患病率的增加、政府和非政府組織(NGO) 推動器官捐贈的舉措不斷增加、專業移植中心的擴張以及不斷變化的醫療保健政策和保險覆蓋範圍，市場正在經歷顯著成長。

移植市場分析：

市場成長與規模：在技術快速進步、慢性病盛行率上升和醫療保健政策改善的推動下，市場正在穩定成長。

主要市場促進因素：影響市場成長的主要促進因素包括醫療技術的快速進步、慢性病導致的器官衰竭發病率上升、移植中心的擴張、政府的支持措施以及不斷變化的醫療保健政策。

主要市場趨勢：主要市場趨勢涉及個人化移植醫學的持續轉變以及生物工程器官和組織的使用。此外，用於開發新免疫抑制藥物和保存解決方案的研發（R&D）投資不斷增加，也促進了市場成長。

地理趨勢：北美因其先進的醫療保健系統、高移植率和強大的器官捐贈網路而引領市場。在醫療基礎設施改善和消費者意識不斷提高的推動下，其他地區也出現了顯著成長。

競爭格局：市場的特徵是主要參與者積極參與策略合併、收購和合作，專注於擴大產品組合和全球影響力。此外，公司也專注於投資研發（R&D），以在藥物配方、組織工程和器官保存技術方面進行創新。

挑戰與機會：市場面臨各種挑戰，例如管理器官捐贈者短缺、器官捐贈的倫理問題以及不同地區醫療保健取得的差異。然而，組織工程的進步和支持公平獲得移植服務的政策的製定正在為市場成長創造新的機會。

移植市場趨勢：

移植技術的快速進步

手術技術、免疫抑制藥物和器官保存方面的不斷進步和創新提高了移植成功率和患者預後，為市場成長創造了積極的前景。與此一致的是，微創（MI）手術方法的發展可減少恢復時間和併發症，從而提高器官移植的可行性和普及度，對市場成長有正面影響。此外，組織分型和匹配技術的快速進步將器官排斥的風險降至最低，正在促進市場成長。同時，數位和人工智慧 (AI) 技術在移植中的整合，可以實現更準確、更快速的器官匹配、預測患者結果和管理移植後護理，正在加強市場成長。

慢性病和器官衰竭的盛行率不斷增加

糖尿病、高血壓和心臟病等慢性病盛行率不斷上升，導致器官移植需求增加，是推動市場成長的主要因素之一。與此一致的是，糖尿病和高血壓導致的腎衰竭發生率不斷上升，全球腎移植的需求不斷增加，推動了市場的成長。同時，越來越多的心臟和肝臟疾病診斷，刺激了心臟和肝臟移植的需求，成為生長誘導因素。除此之外，容易患導致器官衰竭的慢性疾病的老年人口不斷增加，也為市場創造了積極的前景。此外，對各種健康狀況的認知提高和診斷改進，有助於及早識別需要移植的患者，正在促進市場成長。

政府和非政府組織（NGO）不斷採取措施促進器官捐贈

政府和非政府組織（NGO）在促進器官捐贈方面的影響力日益增強，對市場成長產生了正面影響。與此一致的是，越來越多的宣傳活動組織、簡化的捐贈程序和支持性立法，導致器官捐贈者數量的增加，有利於市場的成長。除此之外，政府和非政府組織與醫療保健提供者為簡化器官捐贈流程而迅速開展的合作正在刺激市場成長。同時，在捐贈過程中涵蓋家屬同意的政策的訂定以及國家捐贈登記處的建立正在促進市場的成長。此外，分享器官捐贈最佳實踐和資源並加強全球移植網路的國際合作日益盛行，也支持了市場的成長。

擴大移植中心和服務

全球專業移植中心和服務的不斷成長和擴張正在推動市場成長。專業移植中心配備了先進的設施和熟練的專業人員，能夠執行複雜的移植手術。據此，專門中心的建立，確保更廣泛地獲得移植服務，滿足不斷成長的需要治療的患者群體，正在推動市場成長。此外，這些中心更加重視專業移植和個人化護理，提供全面的護理，包括移植前諮詢、先進的外科手術以及移植後隨訪和康復，這為市場成長提供了動力。此外，中心向農村和服務欠缺地區的擴張，使更廣泛的人群更容易獲得移植服務，正在促進市場成長。

不斷擴大的醫療保健政策和保險覆蓋範圍

支持移植手術的各種政府醫療保健舉措的推出，包括資金、報銷政策和保險範圍，為市場成長提供了相當大的推動力。除此之外，各個醫療系統不斷增加移植手術和成本標準化的努力也有利於市場的成長。除此之外，涵蓋長期術後照護費用的醫療服務一體化，包括免疫抑制藥物和定期監測排斥或併發症的跡象，正在促進市場成長。除此之外，隨著政策制定者解決不同社會經濟群體、種族和地區之間移植率的差異，人們越來越關注移植服務的公平性，也推動了市場的成長。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球移植市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：依產品

  • 紙巾產品
    • 市場走向
    • 市場預測
  • 免疫抑制藥物
    • 市場走向
    • 市場預測
  • 保存液
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按應用

  • 器官移植
    • 市場走向
    • 市場預測
  • 組織移植
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 移植中心
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：促進因素、限制與機會

  • 概述
  • 促進要素
  • 限制
  • 機會

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 21st Century Medicine
    • AbbVie Inc.
    • Arthrex Inc.
    • Astellas Pharma Inc.
    • BioLife Solutions Inc.
    • CareDx Inc.
    • Novartis AG
    • Teva Pharmaceutical Industries Ltd.
    • TransMedics Inc.
    • Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation)
Product Code: SR112024A7197

Abstract

The global transplantation market size reached US$ 16.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 33.6 Billion by 2032, exhibiting a growth rate (CAGR) of 8.39% during 2024-2032. The market is experiencing significant growth driven by rapid advancements in medical technologies, increasing prevalence of chronic diseases, rising initiatives by government and non-governmental organization (NGO) promoting organ donation, expansion of specialized transplantation centers, and the evolving healthcare policies and insurance coverage.

Transplantation Market Analysis:

Market Growth and Size: The market is witnessing stable growth, driven by rapid technological advancements, increasing prevalence of chronic disease, and improved healthcare policies.

Major Market Drivers: Key drivers influencing the market growth include rapid advancements in medical technologies, rising incidence of organ failure due to chronic diseases, expansion of transplantation centers, supportive initiatives by government, and evolving healthcare policies.

Key Market Trends: The key market trends involve the ongoing shift towards personalized transplantation medicine and the use of bio-engineered organs and tissues. Additionally, the increasing investment in research and development (R&D) for developing new immunosuppressive drugs and preservation solutions, is bolstering the market growth.

Geographical Trends: North America leads the market due to its advanced healthcare system, high transplantation rates, and strong organ donation networks. Other regions are also showing significant growth, fueled by the improving healthcare infrastructure and rising consumer awareness.

Competitive Landscape: The market is characterized by the active involvement of key players that are engaged in strategic mergers, acquisitions, and partnerships, focusing on expanding their product portfolios and global presence. Furthermore, companies are focusing on investing in research and development (R&D) to innovate in drug formulations, tissue engineering, and organ preservation technologies.

Challenges and Opportunities: The market faces various challenges, such as managing the organ donor shortage, ethical issues surrounding organ donation, and disparities in healthcare access across different regions. However, advancements in tissue engineering and development of policies to support equitable access to transplant services, are creating new opportunities for the market growth.

Transplantation Market Trends:

Rapid advancements in transplantation technologies

The continuous advancements and innovations in surgical techniques, immunosuppressive medications, and organ preservation that improve transplant success rates and patient outcomes are creating a positive outlook for the market growth. In line with this, the development of minimal invasive (MI) surgical methods to reduce recovery times and complications, thereby increasing the feasibility and popularity of organ transplants is positively impacting the market growth. Moreover, rapid advancements in tissue typing and matching that minimize the risk of organ rejection are fostering the market growth. Along with this, the integration of digital and artificial intelligence (AI) technologies in transplantation for more accurate and quicker organ matching, predicting patient outcomes, and managing post-transplant care is strengthening the market growth.

Increasing prevalence of chronic diseases and organ failure

The rising prevalence of chronic diseases, such as diabetes, hypertension, and heart disease, leading to an increased need for organ transplants, is one of the major factors driving the market growth. In line with this, the growing incidence of kidney failure due to diabetes and hypertension, escalating the demand for kidney transplants across the globe, is providing a thrust to the market growth. Along with this, the increasing diagnosis of heart and liver diseases, spurring the need for heart and liver transplants, is acting as a growth-inducing factor. Besides this, the growing geriatric population who are susceptible to chronic diseases leading to organ failure is creating a positive outlook for the market. Furthermore, the heightened awareness and improved diagnosis of various health conditions, facilitating early identification of patients that require transplants, is catalyzing the market growth.

Rising initiatives by government and non-governmental organizations (NGOs) to promote organ donation

The growing influence of governments and non-governmental organizations (NGOs) in promoting organ donation is positively impacting the market growth. In line with this, the increasing organization of awareness campaigns, simplified donation procedures, and supportive legislation, leading to a rise in the number of organ donors, is favoring the market growth. Besides this, the burgeoning collaboration of the government and NGOs with healthcare providers to streamline the organ donation process is stimulating the market growth. Along with this, the introduction of policies that include family consent in the donation process and the establishment of national donor registries are catalyzing the market growth. Additionally, the heightened prevalence of international collaborations to share best practices and resources in organ donation and strengthen the global transplantation network is supporting the market growth.

Expansion of transplantation centers and services

The rising growth and expansion of specialized transplantation centers and services across the globe are providing a thrust to the market growth. The specialized transplantation centers are equipped with advanced facilities and skilled professionals capable of performing complex transplant procedures. In line with this, the establishment of dedicated centers that ensure wider accessibility to transplantation services, catering to the growing patient population requiring treatment, is boosting the market growth. Additionally, the heightened focus of the centers on specialized transplants and personalized care, offering comprehensive care that includes pre-transplant counseling, advanced surgical procedures, and post-transplant follow-up and rehabilitation, is providing an impetus to the market growth. Furthermore, the expansion of the centers to rural and underserved areas, making transplantation services more accessible to a broader segment of the population, is catalyzing the market growth.

Growing healthcare policies and insurance coverage

The introduction of various government healthcare initiatives that support transplantation procedures, including funding, reimbursement policies, and insurance coverage, is providing a considerable boost to the market growth. Along with this, the increasing efforts to standardize transplant procedures and costs across various healthcare systems are also favoring the market growth. Besides this, the integration of health services that cover the cost of long-term post-operative care, including immunosuppressive medications and regular monitoring for any signs of rejection or complications, is enhancing the market growth. In addition to this, the increasing focus on equity in access to transplant services as policymakers address disparities in transplantation rates among different socio-economic groups, ethnicities, and regions is fueling the market growth.

Transplantation Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, application, and end user.

Breakup by Product:

Tissue Products

Immunosuppressive Drugs

Preservation Solution

Tissue products account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the product. This includes tissue products, immunosuppressive drugs, and preservation solution. According to the report, tissue products represented the largest segment.

Tissue products represent the largest segment in the market due to the high demand for various types of tissues such as corneas, skin, heart valves, bones, and veins. They are employed in a broad range of applications, such as ophthalmic procedures and orthopedic and reconstructive surgeries. Moreover, rapid technological advancements in tissue engineering and grafting techniques are positively impacting the market growth. Additionally, the increasing incidence of conditions requiring tissue transplants, such as burns, trauma, and degenerative diseases, is providing an impetus to the market growth.

Immunosuppressive drugs are essential in transplantation to prevent organ rejection and maintain the long-term viability of the transplant. They include a variety of medications, such as calcineurin inhibitors, corticosteroids, anti-proliferative agents, and mTOR inhibitors. Furthermore, the continuous research and development (R&D) to improve the efficacy of the drugs while minimizing their side effects, is favoring the market growth.

Preservation solutions are critical for maintaining the viability of organs and tissues from the time of donation to transplantation. They are designed to reduce ischemic damage to organs and extend their shelf-life, which is crucial for facilitating transplants over longer distances and improving the overall success rate of transplant surgeries.

Breakup by Application:

Organ Transplantation

Tissue Transplantation

Tissue transplantation holds the largest share in the industry

A detailed breakup and analysis of the transplantation market based on the application has also been provided in the report. This includes organ transplantation and tissue transplantation. According to the report, tissue transplantation accounted for the largest market share.

Tissue transplantation holds the largest market share, as it includes a broad range of procedures, such as skin, corneas, heart valves, bones, and veins. The widespread need for tissue transplantation in various medical conditions and procedures, including burn treatments, reconstructive surgeries, and ophthalmic conditions, is creating a positive outlook for the market growth. Moreover, the increasing prevalence of chronic diseases, accidents, and age-related degenerative conditions, escalating the demand for tissue transplants, is favoring the market growth. In addition to this, rapid advances in tissue engineering and regenerative medicine that improve the outcomes of transplants are catalyzing the market growth.

Organ transplantation involves the transplantation of vital organs, such as the heart, liver, kidney, and lungs. It is driven by the critical need for organ replacements in patients with end-stage organ failure resulting from chronic diseases like diabetes, hypertension, and cardiac diseases. Organ transplantation is characterized by its high complexity and the critical nature of the procedures. The success of organ transplantation heavily depends on timely donor matching, effective immunosuppression to prevent rejection, and advanced surgical techniques.

Breakup by End User:

Hospitals

Transplantation Centers

Others

Hospitals represent the leading market segment

The report has provided a detailed breakup and analysis of the transplantation market based on the end user. This includes hospitals, transplantation centers, and others. According to the report, hospitals represented the largest segment.

Hospitals represent the largest market segment due to their comprehensive healthcare services and the ability to facilitate a wide range of transplant procedures. The dominance of hospitals is attributed to their extensive infrastructure, which includes advanced surgical facilities, intensive care units (ICUs), and specialized transplant departments. Hospitals are the first point of contact for patients requiring transplants, offering services, such as initial diagnosis, evaluation, and post-transplant care. They are equipped to handle complex transplant surgeries and provide comprehensive care, including pre-operative preparation and post-operative monitoring. Additionally, hospitals have larger patient inflows, giving them a broader base for potential transplant candidates.

Transplantation centers are exclusively focused on transplant procedures and providing highly specialized care. They consist of teams of experts who are specifically trained in various aspects of transplantation, including surgeons, transplant coordinators, immunologists, and rehabilitation specialists. Transplantation centers are known for their expertise in handling complex cases and offering cutting-edge treatments, including experimental procedures and clinical trials.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest transplantation market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America leads the transplantation market due to its advanced healthcare infrastructure, high healthcare expenditure, and robust organ donation and transplantation programs. Moreover, the region benefits from a strong presence of leading healthcare companies and research institutions that contribute to the development of innovative transplantation technologies and drugs. Furthermore, North America has one of the highest rates of organ transplantation across the globe, supported by comprehensive regulatory frameworks and a well-organized network of organ procurement organizations. Additionally, the region's focus on research and development (R&D), coupled with favorable government policies and initiatives promoting organ donation, is driving the market growth.

Europe's transplantation market is characterized by advanced healthcare systems and high standards of medical care. Furthermore, the region has a strong network of transplantation centers and a well-established regulatory framework governing organ donation and transplantation. Moreover, the increasing government funding in healthcare, the growing prevalence of chronic diseases requiring transplants, and ongoing research in transplantation medicine are favoring the market growth.

The Asia Pacific region is experiencing rapid growth in the transplantation market, fueled by the increasing prevalence of chronic diseases, improvements in healthcare infrastructure, and rising healthcare expenditures. Additionally, the growing public awareness about organ donation and government initiatives to regulate and promote organ transplantation are contributing to the market growth.

Latin America's transplantation market is growing, driven by several factors, such as the improving healthcare systems and increasing government initiatives to support organ transplantation. Moreover, rapid advancements in transplantation procedures, leading to better outcomes and post-surgery results, are creating a positive outlook for the market growth.

The Middle East and Africa region has seen substantial growth in the transplantation market due to the increasing investments in healthcare infrastructure and growing awareness about transplantation. Additionally, the rising interest in establishing more specialized transplantation centers to address regional needs and improve access to transplant care in the region is favoring the market growth.

Leading Key Players in the Transplantation Industry:

The key players are engaged in a range of strategic activities to strengthen their positions and address the growing demands of the market. They are heavily investing in research and development (R&D) to innovate in areas like immunosuppressive drugs, organ preservation solutions, and bio-engineered tissues. Furthermore, major players are involved in mergers and acquisitions, partnerships with healthcare providers, and collaborations with academic and research institutions to expand their market reach and enhance their product portfolios. Besides this, they are also engaging in initiatives to raise public awareness about organ donation and are involved in policy advocacy to improve transplantation-related healthcare policies.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

21st Century Medicine

AbbVie Inc.

Arthrex Inc.

Astellas Pharma Inc.

BioLife Solutions Inc.

CareDx Inc.

Novartis AG

Teva Pharmaceutical Industries Ltd.

TransMedics Inc.

Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation)

Latest News:

In January 2022, Novartis AG announced a collaboration with Alnylam for exploring targeted therapy to restore liver function with the help of Alnylam's siRNA.

In January 2022, BioLife Solutions extended its collaboration with Seattle Children 's Therapeutics to optimize and enhance biopreservation and closed-system manufacturing by integrating Sexton's AF-500 cell processing tools.

In December 2022, AbbVie Inc. announced its strategic partnership with HotSpot Therapeutics to develop its pipeline for immunology products.

Key Questions Answered in This Report

  • 1. How big is the global transplantation market?
  • 2. What is the expected growth rate of the global transplantation market during 2024-2032?
  • 3. What are the key factors driving the global transplantation market?
  • 4. What has been the impact of COVID-19 on the global transplantation market?
  • 5. What is the breakup of the global transplantation market based on the product?
  • 6. What is the breakup of the global transplantation market based on the application?
  • 7. What is the breakup of the global transplantation market based on the end user?
  • 8. What are the key regions in the global transplantation market?
  • 9. Who are the key players/companies in the global transplantation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transplantation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Tissue Products
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Immunosuppressive Drugs
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Preservation Solution
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Organ Transplantation
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Tissue Transplantation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Transplantation Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 21st Century Medicine
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 AbbVie Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Arthrex Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 SWOT Analysis
    • 14.3.4 Astellas Pharma Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 BioLife Solutions Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 CareDx Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Novartis AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Teva Pharmaceutical Industries Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 TransMedics Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Transplantation Market: Major Drivers and Challenges
  • Figure 2: Global: Transplantation Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Transplantation Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Transplantation Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Transplantation Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Transplantation Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Transplantation Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Transplantation (Tissue Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Transplantation (Tissue Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Transplantation (Immunosuppressive Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Transplantation (Immunosuppressive Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Transplantation (Preservation Solution) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Transplantation (Preservation Solution) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Transplantation (Organ Transplantation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Transplantation (Organ Transplantation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Transplantation (Tissue Transplantation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Transplantation (Tissue Transplantation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Transplantation (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Transplantation (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Transplantation (Transplantation Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Transplantation (Transplantation Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Transplantation (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Transplantation (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: North America: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: North America: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: United States: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: United States: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Canada: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Canada: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Asia-Pacific: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Asia-Pacific: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: China: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: China: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Japan: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Japan: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: India: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: India: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: South Korea: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: South Korea: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Australia: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Australia: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Indonesia: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Indonesia: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Others: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Others: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Europe: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Europe: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Germany: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Germany: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: France: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: France: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: United Kingdom: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: United Kingdom: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Italy: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Italy: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Spain: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Spain: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Russia: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Russia: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Latin America: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Latin America: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Brazil: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Brazil: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Mexico: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Mexico: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Middle East and Africa: Transplantation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Middle East and Africa: Transplantation Market: Breakup by Country (in %), 2023
  • Figure 72: Middle East and Africa: Transplantation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Global: Transplantation Industry: Drivers, Restraints, and Opportunities
  • Figure 74: Global: Transplantation Industry: Value Chain Analysis
  • Figure 75: Global: Transplantation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transplantation Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Transplantation Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Transplantation Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Transplantation Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Transplantation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Transplantation Market: Competitive Structure
  • Table 7: Global: Transplantation Market: Key Players